Market Cap: $17.02B
Market Cap: $17.02B

Revvity, Inc. (Ticker: RVTY) significantly enhances its Signals One platform with the launch of Signals AI, a feature aimed at transforming scientific research through advanced data analytics. Introdu…
AUTOCRYPT Unveils Advanced Post-Quantum Cybersecurity Solution for Automotive Industry AUTOCRYPT, a leader in automotive cybersecurity, announces the launch of "AutoCrypt PKI-Vehicles," a cutting-edge…
Revvity Advances in Digital Identity Management Amidst Competitive PKI Landscape In the rapidly evolving realm of digital security, ABI Research unveils its competitive ranking of leading enterprise P…
Revving Up Digital Identity Management: PKI Solutions Take Center Stage In an era where digital identity management becomes increasingly crucial, ABI Research identifies the leading enterprise Public…
### Revvity's Strategic Growth Amidst Financial Challenges Revvity, Inc. navigates a complex landscape in the third quarter of 2025, showcasing both resilience and the need for strategic recalibration…
Revvity Reports Mixed Q3 Results Amid Growth in Core Segments Revvity, Inc. (NYSE:RVTY) announces its financial results for the third quarter of 2025, revealing both challenges and positive developmen…
Revvity Prepares for Key Earnings Report Amidst Growth Expectations Revvity, a key player in the technology sector, gears up for its quarterly earnings report scheduled for October 27, 2025. This upco…
Revvity’s Strategic Positioning Amid Analyst Scrutiny Revvity, a prominent player in the biopharmaceutical and life sciences sector, faces a critical juncture as analysts provide a mixed bag of evalua…
Revvity Faces Rising Short Interest Amid Market Caution Revvity, a key player in the technology sector specializing in data analytics and software solutions, experiences a notable increase in short in…
Encryption Consulting Launches PKI Assessment Services to Combat Quantum Threats In a decisive move to bolster cybersecurity in the face of emerging quantum threats, Encryption Consulting has introduc…
Strengthening Digital Foundations: Encryption Consulting's New PKI Assessment Services Encryption Consulting, a frontrunner in applied cryptography and cybersecurity, introduces its PKI Assessment Ser…
Revvity Faces Strategic Crossroads Amid Revised Profit Outlook Revvity Inc., a prominent player in the life sciences tools sector, encounters a critical juncture as it adjusts its profit forecast for…
Revvity Prepares for Quarterly Earnings Announcement, Highlighting Sustainable Growth and Strategic Initiatives As Revvity RVTY gears up for its quarterly earnings announcement scheduled for July 28,…
Revvity's Analyst Ratings Reflect Diverse Market Confidence Amidst Industry Challenges Revvity, a company operating within the tech sector, garners attention from nine analysts over the past three mon…
Benzinga's AI-Powered Content Creation: A New Era in Journalism In a significant development within the media industry, Benzinga is at the forefront of integrating artificial intelligence (AI) into it…
Revvity Charts a Steady Course Amid Financial Fluctuations Revvity, Inc. showcases a resilient performance in its recently announced financial results for the fourth quarter and full year ending Decem…
Revvity's Growth Amidst Industry Challenges Revvity, Inc. showcases a notable performance in its fourth quarter and full-year financial results for the period ending December 29, 2024. In Q4, the comp…
Revvity Announces Quarterly Dividend Amid Strong Financial Performance Revvity, a prominent player in the health science solutions sector, announces its intention to distribute a regular quarterly div…
Revvity Partners with Element Biosciences to Enhance Neonatal Sequencing Solutions Revvity, Inc. has entered into a significant strategic agreement with Element Biosciences, Inc., marking a pivotal de…
Revvity Pioneers Testosterone Testing with FDA Clearance for Innovative Immunoassay Revvity, Inc. has made a significant advancement in the field of diagnostic testing with the announcement of its 510…
Revvity Achieves Milestone in Testosterone Testing with FDA Clearance Revvity, Inc. announces a significant advancement in diagnostic testing following the U.S. Food and Drug Administration's (FDA) 51…
Revvity Positioned for Growth in China's Microarray Market The microarray market in China is on a robust growth trajectory, with projections indicating it will reach $910.4 million by 2031, driven by…
Revvity Positioned to Capitalize on Growth in China’s Microarray Market The China microarray market is poised for significant growth, projected to reach $910.4 million by 2031 with a compound annual g…
Sphere Fluidics Expands Global Commercial Operations to Meet Growing Demand Sphere Fluidics, a leader in droplet-based microfluidics solutions for single-cell functional profiling, embarks on a signif…
Emerging Cybersecurity Imperatives in the Age of Quantum Computing and IoT As we approach 2025, the cybersecurity landscape faces transformative challenges driven by advancements in quantum computing…
Quantum Threats and Cybersecurity: The Imperative for Proactive Strategies As the cybersecurity landscape evolves ahead of 2025, organizations face unprecedented challenges primarily driven by the ant…
Revvity Reports Strong Q3 Growth Amid Strategic Developments Revvity, Inc. announces its third-quarter financial results for the period ending September 29, 2024, revealing significant growth metrics…